Silver Book Fact

Studies of patients with myocardial infarction found that warfarin reduced stroke risk compared to placebo
by 40% to 55%.

ASPECT (Anticoagulants in the Secondary Prevention of Events in Coronary Thrombosis) Group. Effect of Long- Term Oral Anticoagulant Treatment on Mortality and Cardiovascular Morbidity After Myocardial Infarction. Lancet. 1994; 343(8896): 499-503. http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2894%2991458-3/abstract

Reference

Title
Effect of Long- Term Oral Anticoagulant Treatment on Mortality and Cardiovascular Morbidity After Myocardial Infarction
Publication
Lancet
Publication Date
1994
Authors
ASPECT (Anticoagulants in the Secondary Prevention of Events in Coronary Thrombosis) Group
Volume & Issue
Volume 343, Issue 8896
Pages
499-503
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Intensive Glycemic Control in People with Diabetes
    Intensive glycemic control in diabetics reduced their: Adjusted mean risk of DR by 76% Risk of progression by 54% Rates of laser surgery by 56% Risk of DME by 23%    
  • Screening and treatment for eye disease in all type 2 diabetes patients would result in an estimated net savings of over $472.1 million– in 1994 dollars.  
  • Nearly 50% of diabetic retinopathy patients who received ranibizumab–an anti-VEGF drug–experienced substantial visual improvement after a year of injections  
  • Lucentis to treat wet age-related macular degeneration (AMD)
    An FDA-approved ophthalmic drug that treats wet age-related macular degeneration (AMD)–ranibizumab (Lucentis)–maintained vision in 95% of clinical trial participants and improved vision by 15 or more letters in approximately 25%…  
  • DR Treatment Savings in the US
    Every year, the U.S. saves an estimated $1.6 billion by treating DR.